Tuesday, 10 May 2022

Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Special https://ift.tt/HAad5FK
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

'Shielding Criminals?' Trinamool Raps MP Over Rape Remark, He Claps Back

The Trinamool Congress, facing a relentless attack from the BJP over the links of the main accused in the Kolkata law student rape case to i...